期刊文献+

肿瘤错配修复基因PMS2及活化Akt1在不同卵巢癌细胞株中的表达及相关性 被引量:1

The expression and the relativity of PMS2 and P-Akt S473 in different human ovarian cancer cell lines
下载PDF
导出
摘要 目的检测Akt1、P-Akt S473和PMS2蛋白在人类不同卵巢癌细胞株(A2780、Caov3、C13*和ES2)中的表达水平及相关性。方法应用Western blot检测Akt1、P-Akt S473和PMS2蛋白分别于A2780、Caov3、C13*和ES2细胞中表达水平;应用Akt1激动剂胰岛素样生长因子-1(IGF-1)及Akt1特异性抑制剂API-2调节Akt1活化水平,观察PMS2蛋白表达水平变化。结果 Akt1,P-Akt S473及PMS2 3种蛋白在A2780,Caov3,C13*和ES2卵巢癌细胞内均表达,但表达水平高低不一,即Akt1的活化形式P-Akt S473与PMS2蛋白表达呈负相关;应用IGF-1上调Akt1的活性后,ES2和Caov3中PMS2表达水平明显下降,且与IGF-1的作用存在时间依赖性;应用特异性抑制剂API-2抑制Akt1的活性后,A2780中PMS2表达水平明显升高,且与API-2的作用存在时间依赖性。结论人类卵巢癌细胞中PMS2蛋白的表达水平可能受活化Akt1的直接调控。 Objective To evaluate the expression and the relativity of PMS2,Akt1 and P-Akt S473 protein in A2780,Caov3,C13*and ES2 ovarian cancer cell lines.Methods The expression of PMS2,Akt1 and P-Akt S473 protein in A2780,Caov3,C13*and ES2 ovarian cancer cells was detected by Western Blot.After treated with IGF-1(Akt1activator)and API-2(specific Akt1inhibitor),Caov3,ES2 and A2780cells were collected and the level of PMS2 was detected by Western Blot.Results PMS2,Akt1 and P-Akt S473 proteins were detected in all of the four ovarian cancer cell lines with varied expression levels,and the activity of Akt1 was inversely related to PMS2 expression in ovarian cancer cells.Exposed to Akt kinase stimulator IGF-1,ES2 and Caov3cells were detected with a dramatically PMS2 decreasing.Meanwhile,the decreasing of PMS2 protein was time-dependent on IGF-1.Treated with API-2,Akt kinase specific inhibitor,A2780 was detected with PMS2 dramatically increasing,and the increasing of PMS2 protein was time-dependent on API-2.Conclusion In ovarian cancer cells,PMS2 expression could be directly regulated by activated Akt1.
出处 《重庆医学》 CAS 北大核心 2016年第9期1183-1185,共3页 Chongqing medicine
关键词 卵巢肿瘤 蛋白激酶类 胰岛素样生长因子1 ovarian neoplasms protein kinases insulin-like growth factor 1
  • 相关文献

参考文献24

  • 1Alessi DR,Caudwell FB, Andjelkovic M, et al. Molecular basis for the substrate specificity of protein kinase B comparison with MAPKAP kinase-1 and p70 $6 kinase [J]. Febs Lett,1996,399(3) :333-338.
  • 2Fink D, Aebi S, Howell SB. The role of DNA mismatch repair in drug resistance[J]. Clin Cancer Res, 1998,4 (1) : 1-6.
  • 3Norris RD,Woodruff RB,DrAgostino RB, et al. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer[J]. Prostate, 2007,67 (2) .. 214-225.
  • 4Datta SR, Brunet A, Greenberg ME. Cellular survival., a play in three Akts[J]. Genes Dev, 1999,13(22) 2905-2927.
  • 5Yang L,Dan HC,Sun M,et al. Akt/protein kinase B sig- naling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells over- expressing Akt[J]. Cancer Res, 2004,64 (13) : 4394-4399.
  • 6H u Y, Qiao L, Wang S, et al. 3-( Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth[J]. J Med Chem,2000,43(16) .-3045-3051.
  • 7Boyer JC,Umar A, Risinger JI, et al. Microsatellite insta- bility, mismatch repair deficiency, and genetic defects in human cancer cell lines[J]. Cancer Res, 1995,55 (24) : 6063-6070.
  • 8Su CH, Wang CY, Lan KH, et al. Akt phosphorylation at Thr308 and Ser473 is required for CHIP-mediated ubiq- uitination of the kinase[J]. Cell Signal, 2011,23 (11) 1824-1830.
  • 9Fishel R. The selection for mismatch repair defects in he- reditary nonpolyposis colorectal cancer revising the muta- tor hypothesis[J]. Cancer Res, 2001,61 (20) .. 7369-7374.
  • 10Modrich P. Mismatch repair, genetic stability, and cancer [J]. Science, 1994,266 (5193) .. 1959-1960.

同被引文献18

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部